The presence of this medication in Oz is creating significant excitement within the medical community. This groundbreaking dual medication – acting on both GLP-1 and GIP targets – shows a potentially powerful tool https://australianpeptidestore.co/bpc-157-10mg-research-peptide-australian-peptide-store/